These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The ScaI gene polymorphism of the atrial natriuretic factor and essential arterial hypertension in childhood. Zorc-Plesković R, Bidovec M, Bregar D, Milutinović A, Terzić R, Teran N. Coll Antropol; 2004 Dec; 28(2):617-21. PubMed ID: 15666592 [Abstract] [Full Text] [Related]
3. Renin-angiotensin system gene polymorphisms: assessment of the risk of coronary heart disease. Buraczyńska M, Pijanowski Z, Spasiewicz D, Nowicka T, Sodolski T, Widomska - Czekajska T, Ksiazek A. Kardiol Pol; 2003 Jan; 58(1):1-9. PubMed ID: 14502296 [Abstract] [Full Text] [Related]
4. Gene polymorphisms of the renin-angiotensin system and early development of hypertension. Barbalić M, Skarić-Jurić T, Cambien F, Barbaux S, Poirier O, Turek S, Vrhovski-Hebrang D, Cubrilo-Turek M, Rudan I, Rudan P, Narancić NS. Am J Hypertens; 2006 Aug; 19(8):837-42. PubMed ID: 16876684 [Abstract] [Full Text] [Related]
8. Haplotype-based association of the renin-angiotensin-aldosterone system genes polymorphisms with essential hypertension among Han Chinese: the Fangshan study. Niu W, Qi Y, Hou S, Zhai X, Zhou W, Qiu C. J Hypertens; 2009 Jul; 27(7):1384-91. PubMed ID: 19412130 [Abstract] [Full Text] [Related]
9. Significance of angiotensinogen gene haplotypes and genotypes combinations in hypertension. Nejatizadeh A, Kumar R, Stobdan T, Goyal AK, Gupta M, Javed S, Pasha MQ. J Hypertens; 2008 Jun; 26(6):1094-101. PubMed ID: 18475146 [Abstract] [Full Text] [Related]
11. [Genetic polymorphisms of the renin-angiotensin system and essential hypertension]. Fernández-Llama P, Poch E, Oriola J, Botey A, de la Sierra A, Revert L, Rivera F, Darnell A. Med Clin (Barc); 1999 May 01; 112(15):561-4. PubMed ID: 10365380 [Abstract] [Full Text] [Related]
13. Angiotensinogen M235T polymorphism and the risk of myocardial infarction and stroke among hypertensive patients on ACE-inhibitors or beta-blockers. Schelleman H, Klungel OH, Witteman JC, Breteler MM, Yazdanpanah M, Danser AH, Hofman A, van Duijn CM, de Boer A, Stricker BH. Eur J Hum Genet; 2007 Apr 01; 15(4):478-84. PubMed ID: 17299437 [Abstract] [Full Text] [Related]
14. Genetic variation in the renin-angiotensin system modifies the beneficial effects of ACE inhibitors on the risk of diabetes mellitus among hypertensives. Bozkurt O, Verschuren WM, van Wieren-de Wijer BM, Knol MJ, de Boer A, Grobbee DE, Geerlings MI, Heerdink ER, Klungel OH. J Hum Hypertens; 2008 Nov 01; 22(11):774-80. PubMed ID: 18563171 [Abstract] [Full Text] [Related]
15. Genetic polymorphisms in the renin-angiotensin system confer increased risk of stroke independently of blood pressure: a nested case-control study. Möllsten A, Stegmayr B, Wiklund PG. J Hypertens; 2008 Jul 01; 26(7):1367-72. PubMed ID: 18551012 [Abstract] [Full Text] [Related]
18. The M235T polymorphism in the angiotensinogen gene is associated with the risk of malignant hypertension in white patients. van den Born BJ, van Montfrans GA, Uitterlinden AG, Zwinderman AH, Koopmans RP. J Hypertens; 2007 Nov 01; 25(11):2227-33. PubMed ID: 17921816 [Abstract] [Full Text] [Related]